JP2024526878A5 - - Google Patents

Info

Publication number
JP2024526878A5
JP2024526878A5 JP2024503529A JP2024503529A JP2024526878A5 JP 2024526878 A5 JP2024526878 A5 JP 2024526878A5 JP 2024503529 A JP2024503529 A JP 2024503529A JP 2024503529 A JP2024503529 A JP 2024503529A JP 2024526878 A5 JP2024526878 A5 JP 2024526878A5
Authority
JP
Japan
Prior art keywords
retrovirus
polynucleotide
cancer
activator
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024503529A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024526878A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074024 external-priority patent/WO2023004396A1/en
Publication of JP2024526878A publication Critical patent/JP2024526878A/ja
Publication of JP2024526878A5 publication Critical patent/JP2024526878A5/ja
Pending legal-status Critical Current

Links

JP2024503529A 2021-07-21 2022-07-21 調節されたウイルス送達システムおよびその使用 Pending JP2024526878A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163224330P 2021-07-21 2021-07-21
US63/224,330 2021-07-21
PCT/US2022/074024 WO2023004396A1 (en) 2021-07-21 2022-07-21 Regulated viral delivery systems and their uses

Publications (2)

Publication Number Publication Date
JP2024526878A JP2024526878A (ja) 2024-07-19
JP2024526878A5 true JP2024526878A5 (cg-RX-API-DMAC7.html) 2025-07-28

Family

ID=84980508

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503529A Pending JP2024526878A (ja) 2021-07-21 2022-07-21 調節されたウイルス送達システムおよびその使用

Country Status (4)

Country Link
US (1) US20240327866A1 (cg-RX-API-DMAC7.html)
EP (1) EP4373952A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024526878A (cg-RX-API-DMAC7.html)
WO (1) WO2023004396A1 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705686B1 (fr) * 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
JPH1080274A (ja) * 1996-09-06 1998-03-31 Hirofumi Hamada 核移行シグナルを結合したテトラサイクリン・トランスアクチベーター
EP1059356B1 (en) * 1999-06-09 2005-11-02 Universite Pierre Et Marie Curie Paris Vi Replicating retroviral constructs, preparation and uses for gene delivery
EP1059357A1 (en) * 1999-06-09 2000-12-13 Universite Pierre Et Marie Curie Paris Vi Replicating or semi-replicating retroviral constructs, preparation and uses for gene delivery
WO2001091802A1 (en) * 2000-05-30 2001-12-06 Baylor College Of Medicine Chimeric viral vectors for gene therapy
WO2019055946A1 (en) * 2017-09-18 2019-03-21 F1 Oncology, Inc. METHODS AND COMPOSITIONS FOR THE GENETIC MODIFICATION AND EXPANSION OF LYMPHOCYTES AND THE REGULATION OF THE ACTIVITY THEREOF
KR102409077B1 (ko) * 2017-03-24 2022-06-15 칭화 유니버시티 프로그램 가능한 항암 바이러스 백신 시스템 및 이의 적용

Similar Documents

Publication Publication Date Title
US20240182924A1 (en) Genomic insulator elements and uses thereof
JP5265643B2 (ja) 免疫治療組成物調製用のレンチウイルスベクター
Renaud-Gabardos et al. Internal ribosome entry site-based vectors for combined gene therapy
CN105705645B (zh) 逆转录病毒载体
Reichenbach et al. A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptor
EP2909324B1 (en) Retroviral vector with mini-promoter cassette
JP7672114B2 (ja) 安定したレンチウイルスパッケージング細胞株およびその作成方法
Diaz et al. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy
CN1234075A (zh) 慢病毒载体
JP2012503986A5 (cg-RX-API-DMAC7.html)
JP2016526920A5 (cg-RX-API-DMAC7.html)
CA2346931A1 (en) Gene delivery system and methods of use
CN105579581A (zh) 具有优化的a凸出物的重组载体
US20240401077A1 (en) Koala retrovirus envelope gylcoproteins and uses thereof
KR20020013486A (ko) 전사 조절부위로서 이종 유전자의 프로모터와 원래 유전자시작 코돈의 상부에 위치한 모든 5' 비해독 부위를 갖는고효율 동물세포 발현벡터
Hofacre et al. Efficient therapeutic protein expression using retroviral replicating vector with 2A peptide in cancer models
JP2024503703A5 (cg-RX-API-DMAC7.html)
EP1478750B1 (en) Gene expression by positive feedback activation of a cell type-specific promoter
EP1045922B1 (en) Reconstituting retroviral vector (recon vector) for targeted gene expression
JPH11502706A (ja) シュードタイプレトロウイルス粒子
JP2001502904A (ja) レトロウイルスベクター
CN117866107A (zh) 靶向cd5分子的嵌合抗原受体t细胞及其抗肿瘤应用
WO2018101498A1 (ko) 유전자치료 벡터시스템 및 전구약물 유전자
EP1059356B1 (en) Replicating retroviral constructs, preparation and uses for gene delivery
Roth et al. MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors